Both combinations reduced tumor burden more effectively than monotherapy, confirming that dual targeting of PHGDH’s enzymatic and RBP functions is a viable combination strategy for HCC (Fig. 7h–j). Here, PHGDH is linked to hepatocellular carcinoma.